Subscribe To

Price Alert Latest News Economic Calendar News

CTSO / CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference

CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification, announced the public availability of preliminary data abstracts from two separate endocarditis studies, including the REMOVE study, to be presented at the upcoming European Association for Cardio-Thoracic Surgery (EACTS) annual meeting taking place in Barcelona, Spain from October 13-16, 2021, where more extensive data are expected to be made available. Read More

Demo Live Account See Partner Details

Content Topics

Eaton

Vance

Tax

Managed

Diversified

Equity

Income

Fund

Ety

Cytosorbents

Announces

Availability

Preliminary

Abstracts

Endocarditis

Studies

Including

Remove

Study

Presented

Conference

Stock

CTSO

Posted: Oct 7 2021, 15:11

Author Name: PRNewsWire

CTSO News

By Seeking Alpha
August 1, 2023

Cytosorbents Corporation (CTSO) Q2 2023 Results Earnings Conference Call

Cytosorbents Corporation. (NASDAQ:CTSO ) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Taylor Devlin - Revenue Accou

By Seeking Alpha
May 2, 2023

Cytosorbents Corporation (CTSO) Q1 2023 Earnings Call Transcript

Cytosorbents Corporation (NASDAQ:CTSO ) Q1 2023 Results Earnings Conference Call May 2, 2023 4:30 AM ET Company Participants Taylor Devlin - Revenue A

By Seeking Alpha
March 9, 2023

Cytosorbents Corporation (CTSO) Q4 2022 Earnings Call Transcript

Cytosorbents Corporation (NASDAQ:CTSO ) Q4 2022 Earnings Conference Call March 9, 2023 4:30 PM ET Company Participants Jodi Hoover – Manager-Clinica

By PRNewsWire
February 24, 2023

CytoSorbents to Report Fiscal 2022 Operating and Financial Results

MONMOUTH JUNCTION, N.J. , Feb. 24, 2023 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condit

By Seeking Alpha
November 5, 2022

CytoSorbents Corporation (CTSO) Q3 2022 Earnings Call Transcript

CytoSorbents Corporation (NASDAQ:CTSO ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Michelle Almonte - Executive

By Seeking Alpha
August 2, 2022

Cytosorbents Corporation's (CTSO) CEO Phillip Chan on Q2 2022 Results - Earnings Call Transcript

Cytosorbents Corporation (NASDAQ:CTSO ) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Amy Vogel – Investor Relatio

By PRNewsWire
July 25, 2022

CytoSorbents to Report Second Quarter 2022 Operating and Financial Results

PRINCETON, N.J. , July 25, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in

By Seeking Alpha
May 7, 2022

Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q1 2022 Results - Earnings Call Transcript

Cytosorbents Corporation (NASDAQ:CTSO ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Terri Anne Powers - Vice Presiden

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.